Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
Di | HeartSciences Inc. - 8-K, Current Report | - | SEC Filings | ||
16.12.24 | Heart Test Laboratories GAAP EPS of -$2.27 beats by $0.21 | 3 | Seeking Alpha | ||
16.12.24 | Heart Test Laboratories, Inc.: HeartSciences Provides Business Update and Reports Second Quarter Fiscal 2025 Financial Results | 104 | GlobeNewswire (Europe) | Southlake, TX, Dec. 16, 2024 (GLOBE NEWSWIRE) -- HeartSciences Inc. (Nasdaq: HSCS; HSCSW) ("HeartSciences" or the "Company"), an artificial intelligence (AI)-powered medical technology company focused... ► Artikel lesen | |
16.12.24 | HeartSciences Inc. - 8-K, Current Report | - | SEC Filings | ||
16.12.24 | HeartSciences Inc. - 10-Q, Quarterly Report | - | SEC Filings | ||
13.11.24 | Heart Test Laboratories, Inc.: HeartSciences' AI-ECG Algorithms Assigned CMS Medicare and Medicaid Reimbursement | 1 | GlobeNewswire (USA) | ||
08.11.24 | HeartSciences shareholders approve auditor and meeting adjournment | 2 | Investing.com | ||
HEARTSCIENCES Aktie jetzt für 0€ handeln | |||||
08.11.24 | HeartSciences Inc. - 8-K, Current Report | - | SEC Filings | ||
18.10.24 | Heart Test Laboratories kündigt Änderung des Firmennamens in HeartSciences an | 2 | Investing.com Deutsch | ||
18.10.24 | Heart Test Laboratories announces corporate name change to HeartSciences | 3 | Investing.com | ||
18.10.24 | Heart Test Laboratories, Inc. - 8-K, Current Report | 2 | SEC Filings | ||
14.10.24 | Heart Test Laboratories, Inc.: HeartSciences to Participate in the 2024 Maxim Healthcare Virtual Summit | 1 | GlobeNewswire (USA) | ||
27.09.24 | Heart Test Laboratories, Inc. - S-1/A, General form for registration of securities | 4 | SEC Filings | ||
24.09.24 | Pre-market Movers: Maison Solutions, Heart Test Laboratories, BioVie, Generations Bancorp NY, Liberty Broadband | 523 | AFX News | CANBERA (dpa-AFX) - The following are some of the stocks making big moves in Tuesday's pre-market trading (as of 07.45 A.M. ET).In the Green Maison Solutions Inc. (MSS) is up over 99% at $1.47.
Heart... ► Artikel lesen | |
12.09.24 | Heart Test Laboratories GAAP EPS of -$2.64 misses by $0.18 | 2 | Seeking Alpha | ||
12.09.24 | Heart Test Laboratories, Inc.: HeartSciences Provides Business Update and Reports First Quarter Fiscal 2025 Financial Results | 365 | GlobeNewswire (Europe) | Southlake, TX, Sept. 12, 2024 (GLOBE NEWSWIRE) -- Heart Test Laboratories, Inc. d/b/a HeartSciences (Nasdaq: HSCS; HSCSW) ("HeartSciences" or the "Company"), an artificial intelligence (AI)-powered... ► Artikel lesen | |
12.09.24 | Heart Test Laboratories, Inc. - 10-Q, Quarterly Report | 2 | SEC Filings | ||
12.09.24 | Heart Test Laboratories, Inc.: HeartSciences Closes Non-Dilutive Financing to Increase its Cash Runaway Ahead of Upcoming FDA Submission | 1 | GlobeNewswire (USA) | ||
10.09.24 | Heart Test Laboratories, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
06.09.24 | Heart Test Laboratories stock touches 52-week low at $3.01 amid sharp annual decline | 1 | Investing.com |
Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
---|---|---|---|---|---|
CARL ZEISS MEDITEC | 52,30 | +5,66 % | BERENBERG stuft CARL ZEISS MEDITEC AG auf 'Hold' | HAMBURG (dpa-AFX Analyser) - Die Privatbank Berenberg hat das Kursziel für Carl Zeiss Meditec von 66 auf 50 Euro gesenkt und die Einstufung auf "Hold" belassen. Sollten sich die Endabnehmermärkte von... ► Artikel lesen | |
FRESENIUS | 36,780 | +2,42 % | Leichte Zugewinne bei der Fresenius SE & Co. KGaA-Aktie (36,58 €) | Das Wertpapier von Fresenius SE & Co. KGaA notiert heute fester. Der jüngste Kurs betrug 36,58 Euro. Die Fresenius+Co KgaA-Aktie verzeichnet gegenwärtig einen Wertanstieg von 2,75 Prozent. Sie hat sich... ► Artikel lesen | |
FRESENIUS MEDICAL CARE | 46,130 | +3,76 % | Fresenius Medical Care Aktie: Richtung stimmt! | Die Fresenius Medical Care-Aktie setzt ihren positiven Trend fort und verzeichnet am 19. Januar 2025 einen Kursanstieg von 0,04 Prozent auf 44,88 EUR. Die Entwicklung der vergangenen Wochen zeigt eine... ► Artikel lesen | |
SIEMENS HEALTHINEERS | 54,26 | +0,56 % | UBS stuft Siemens Healthineers auf 'Neutral' | ZÜRICH (dpa-AFX Analyser) - Die Schweizer Großbank UBS hat die Einstufung für Siemens Healthineers mit einem Kursziel von 53 Euro auf "Neutral" belassen. Im europäischen Medizintechnik-Bereich gebe... ► Artikel lesen | |
GERRESHEIMER | 65,00 | -1,07 % | EQS-PVR: Gerresheimer AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution | EQS Voting Rights Announcement: Gerresheimer AG
Gerresheimer AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of... ► Artikel lesen | |
PROCEPT BIOROBOTICS | 68,42 | 0,00 % | PROCEPT BioRobotics (NASDAQ:PRCT) Trading Down 2.8% - Should You Sell? | ||
BRIGHTSPRING HEALTH SERVICES | 21,210 | 0,00 % | BrightSpring Health Services, Inc. Enters into Definitive Agreement to Divest Community Living Business to Sevita; Reports Preliminary 2024 Financial Results and Provides 2025 Guidance Excluding Community Living | Streamlined organization and Provider Services segment to optimize resource allocationProvider Services focus on Home Health/Hospice, Personal Care, Rehabilitation Services, and Care Management strategic... ► Artikel lesen | |
BIOTEST | 27,000 | +0,37 % | Aktien KW 2 - US-Jobmarkt verdirbt die Party? Woche mit Paukenschlag. News. Auto1. Mutares. Nvidia. Kion. Magirus. Fuchs. INDUS. Biotest. Circus | Aktien Wochenrückblick - nach zwei ruhigen feiertagsgeprägten Wochen sah es diese Woche wieder so aus, als ob der DAX wieder auf Rekordkurs gehen wollte. Angebrannt ist nichts, aber die US-Jobdaten... ► Artikel lesen | |
NANO-X IMAGING | 8,980 | 0,00 % | Nano-X Imaging LTD.: Nanox.ARC Imaging System Receives FDA Clearance for General Use, Including Pulmonary Indication | Nanox.ARC receives additional FDA clearance to produce tomographic images for general use, including pulmonary, intra-abdominal and paranasal indications, in addition to its previously cleared indication... ► Artikel lesen | |
PRIVIA HEALTH GROUP | 22,680 | 0,00 % | Privia Health Group, Inc.: Privia Health Reports Third Quarter 2024 Financial Results | Strong Execution Across All Business and Financial MetricsRaised Full-Year 2024 Guidance to At or Above the High End for All MetricsAnnounced New Market Entry in Indiana Achieved MSSP 2023 Shared... ► Artikel lesen | |
GENEDX | 75,69 | 0,00 % | GeneDx Announces Preliminary 2024 Financial Results | STAMFORD, Conn.--(BUSINESS WIRE)--GeneDx Holdings Corp. (Nasdaq: WGS), a leader in delivering improved health outcomes through genomic insights, today reported preliminary financial results for... ► Artikel lesen | |
ATRICURE | 39,490 | 0,00 % | Deep Dive Into AtriCure Stock: Analyst Perspectives (9 Ratings) | ||
PROGYNY | 21,155 | 0,00 % | Witness A Substantial Acquisition As DEBRA MORRIS Acquires Progyny Stock Options Worth $37K | ||
ALIGNMENT HEALTHCARE | 14,610 | 0,00 % | Alignment Healthcare is latest to sue Medicare over Star Ratings | ||
RXSIGHT | 31,930 | 0,00 % | RxSight, Inc. Announces Preliminary Unaudited Fourth Quarter and Full-Year 2024 Financial and Operational Results and 2025 Guidance | ALISO VIEJO, Calif., Jan. 12, 2025 (GLOBE NEWSWIRE) -- (NASDAQ: RXST) - RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following... ► Artikel lesen |